Guardant Health shares are trading lower after Leerink Partners lowered its price target on the stock from $60 to $50.
Portfolio Pulse from Benzinga Newsdesk
Guardant Health shares declined after Leerink Partners reduced its price target from $60 to $50.
October 17, 2024 | 7:17 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Guardant Health's stock price is under pressure following Leerink Partners' decision to lower its price target from $60 to $50.
The reduction in price target by Leerink Partners is likely to negatively impact investor sentiment, leading to a short-term decline in Guardant Health's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100